The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Cigna ( (CI) ) has released its Q3 earnings. Here is a breakdown of the information Cigna presented to its investors. The Cigna Group is a ...

CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset ...

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

Cigna exceeded quarterly profit projections, fueled by high demand for specialty drugs and new clients in its pharmacy benefit management sector. The company enjoyed a 2% premarket share increase and ...

Investing.com - Cigna Corp (NYSE:CI) has confirmed it is not pursuing a combination with its smaller peer Humana (NYSE:HUM), ...

Cigna Healthcare was also continuing ... significant growth within our specialty and care services business in the third quarter. Total Evernorth revenues for third quarter 2024 grew to $52.5 ...